County
Adams, Benton, Franklin, Yakima Counties EMS
Adams, Benton, Franklin, Yakima Counties EMS (WA) carries 43 drugs across 146 dose entries in its current published protocol, effective 2025-01-01.
Drugs and doses43
Acetaminophen
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 650–1000 mg | PO | not captured | standing | page 52 |
| Mild to moderate pain | peds | 15 mg/kg | PO | not captured | standing | page 52 |
| Seizure | peds | 20 mg/kg | PR | not captured | standing | page 74 |
Adenosine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| SVT | adult | 6 mg | IV | not captured | standing | page 45 |
| SVT | peds | 0.1 mg/kg | IV | not captured | standing | page 45 |
Albuterol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mg | NEB | not captured | standing | page 54 |
| Asthma / bronchospasm | peds | 2.5 mg | NEB | not captured | standing | page 54 |
Amiodarone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 300 mg | IV/IO | not captured | standing | page 43 |
| Cardiac arrest | peds | 5 mg/kg | IV/IO | not captured | standing | page 43 |
| Wide-complex tachycardia | adult | 150 mg | IV | not captured | standing | page 45 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV | not captured | standing | page 45 |
Aspirin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 324 mg | PO | not captured | standing | page 39 |
Atropine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 1 mg | IV | not captured | standing | page 37 |
| Bradycardia | peds | 0.02 mg/kg | IV | not captured | standing | page 37 |
| Organophosphate poisoning | peds | 0.05 mg/kg | IV | not captured | standing | page 172 |
| RSI induction | adult | 1 mg | IV | not captured | standing | page 110 |
| RSI induction | peds | 0.02 mg/kg | IV | not captured | standing | page 110 |
Calcium Chloride
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1 g | IV | not captured | standing | page 73 |
Calcium Gluconate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Beta-blocker / calcium-channel-blocker overdose | adult | 1–2 g | IV | not captured | standing | page 49 |
| Hyperkalemia | adult | 1–2 g | IV | not captured | standing | page 49 |
Dextrose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 25 g | IV/IO | not captured | standing | page 64 |
| Hypoglycemia | peds | 0.5–1 g/kg | IV/IO | not captured | standing | page 64 |
| Other | adult | 25 g | IV | not captured | standing | page 76 |
Diazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 2–5 mg | IV/IM | not captured | standing | page 176 |
| Agitation | adult | 2–5 mg | IV/IM | not captured | standing | page 176 |
| Procedural sedation | adult | 2–10 mg | IV/IM | not captured | standing | page 176 |
| Procedural sedation | peds | 0.1–0.3 mg/kg | IV/IM | not captured | standing | page 176 |
| Seizure | adult | 2–10 mg | IV/IM | not captured | standing | page 176 |
| Seizure | peds | 0.1–0.3 mg/kg | IV/IM | not captured | standing | page 176 |
Diltiazem
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 176 |
| Atrial fibrillation with RVR | adult | 0.25 mg/kg | IV | not captured | standing | page 176 |
| SVT | adult | 0.25 mg/kg | IV | not captured | standing | page 176 |
Diphenhydramine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 25–50 mg | IV/IO/IM/PO | not captured | standing | page 54 |
| Allergic reaction | peds | 1–2 mg/kg | IV/IO/IM/PO | not captured | standing | page 54 |
| Dystonic reaction | adult | 25–50 mg | IV/IM/PO | not captured | standing | page 177 |
Dopamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Bradycardia | adult | 2–10 mcg/kg | IV/IO | not captured | standing | page 177 |
| Bradycardia | peds | 2–10 mcg/kg | IV/IO | not captured | standing | page 177 |
Droperidol
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 5 mg | IV/IM | not captured | standing | page 57 |
Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Allergic reaction | adult | 0.3–0.5 mg | IM | not captured | standing | page 178 |
| Allergic reaction | peds | 0.01 mg/kg | IM | not captured | standing | page 178 |
| Anaphylaxis | adult | 0.3–0.5 mg | IV/IO | not captured | standing | page 178 |
| Anaphylaxis | adult | 0.3–0.5 mg | IM | not captured | standing | page 178 |
| Anaphylaxis | peds | 0.01 mg/kg | IM | not captured | standing | page 178 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IV | not captured | standing | page 178 |
| Asthma / bronchospasm | adult | 0.3–0.5 mg | IM | not captured | standing | page 178 |
| Asthma / bronchospasm | peds | 0.01 mg/kg | IM | not captured | standing | page 178 |
| Bradycardia | adult | 2–10 mcg | IV/IO | not captured | standing | page 179 |
| Bradycardia | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 179 |
| Cardiac arrest | adult | 1 mg | IV/IO | not captured | standing | page 178 |
| Cardiac arrest | peds | 0.01 mg/kg | IV/IO | not captured | standing | page 178 |
| Hypotension / shock | adult | 5–20 mcg | IV | not captured | standing | page 178 |
Etomidate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 0.3 mg/kg | IV | not captured | standing | page 108 |
Fentanyl
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 2 mcg/kg | IN | not captured | standing | page 118 |
| Mild to moderate pain | adult | 50 mcg | IV/IO/IM | not captured | standing | page 118 |
| Mild to moderate pain | peds | 1 mcg/kg | IV/IO/IM | not captured | standing | page 118 |
| RSI induction | adult | 1–3 mcg/kg | IV | not captured | standing | page 109 |
Glucagon
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2 mg | IV | not captured | standing | page 38 |
| Hypoglycemia | adult | 1 mg | IM | not captured | standing | page 64 |
| Hypotension / shock | adult | 2 mg | IV | not captured | standing | page 38 |
| Hypotension / shock | peds | 0.1 mg/kg | IV | not captured | standing | page 38 |
Ipratropium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 79 |
| Asthma / bronchospasm | adult | 2.5 mL | NEB | not captured | standing | page 79 |
| Asthma / bronchospasm | peds | 2.5 mL | NEB | not captured | standing | page 79 |
| Asthma / bronchospasm | peds | 2.5 mL | NEB | not captured | standing | page 79 |
| COPD | adult | 2.5 mL | NEB | not captured | standing | page 81 |
Ketamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 1–2 mg/kg | IV | not captured | standing | page 57 |
| Agitation | adult | 250 mg | IM | not captured | standing | page 57 |
| Agitation | peds | 1 mg/kg | IV | not captured | standing | page 57 |
| Agitation | peds | 4 mg/kg | IM | not captured | standing | page 57 |
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 118 |
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 108 |
Ketorolac
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Mild to moderate pain | adult | 15 mg | IV | not captured | standing | page 118 |
| Mild to moderate pain | adult | 30 mg | IM | not captured | standing | page 118 |
Lidocaine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 0.5–0.75 mg/kg | IV/IO | not captured | standing | page 45 |
| Other | adult | 20–50 mg | IO | not captured | standing | page 100 |
| VF / pulseless VT | adult | 1–1.5 mg/kg | IV/IO | not captured | standing | page 43 |
| VF / pulseless VT | peds | 1 mg/kg | IV/IO | not captured | standing | page 43 |
Lorazepam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 1–2 mg | IV/IM/IN | not captured | standing | page 73 |
| Agitation | adult | 1–2 mg | IV/IM/IN | not captured | standing | page 185 |
| Eclampsia / pre-eclampsia | adult | 2–4 mg | IV | not captured | standing | page 70 |
| Other | adult | 0.5–1 mg | IV | not captured | standing | page 185 |
| Procedural sedation | adult | 1–2 mg | IV/IM/IN | not captured | standing | page 185 |
| Procedural sedation | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 185 |
| Seizure | adult | 2–4 mg | IV/IM/IN | not captured | standing | page 75 |
| Seizure | peds | 0.1 mg/kg | IV/IM/IN | not captured | standing | page 75 |
Magnesium Sulfate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Eclampsia / pre-eclampsia | adult | 2–4 g | IV | not captured | standing | page 70 |
| Other | adult | 2 g | IV | not captured | standing | page 186 |
| Wide-complex tachycardia | adult | 2 g | IV | not captured | standing | page 186 |
| Tricyclic overdose | adult | 2 g | IV | not captured | standing | page 72 |
| VF / pulseless VT | adult | 2 g | IV | not captured | standing | page 43 |
Methylprednisolone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Anaphylaxis | adult | 125 mg | IV | not captured | standing | page 55 |
| Anaphylaxis | peds | 1–2 mg/kg | IV | not captured | standing | page 55 |
| Asthma / bronchospasm | adult | 125 mg | IV | not captured | standing | page 79 |
| Asthma / bronchospasm | peds | 1–2 mg/kg | IV | not captured | standing | page 79 |
| COPD | adult | 125 mg | IV | not captured | standing | page 81 |
| COPD | peds | 1–2 mg/kg | IV | not captured | standing | page 81 |
Metoclopramide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 5–10 mg | IV/IM | not captured | standing | page 53 |
Midazolam
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Procedural sedation | adult | 1–5 mg | IV/IM/IN | not captured | standing | page 186 |
| Procedural sedation | peds | 0.5–1 mg | IV/IM/IN | not captured | standing | page 186 |
| RSI induction | adult | 2.5–5 mg | IV/IM | not captured | standing | page 108 |
Morphine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| CHF / pulmonary edema | adult | 2–4 mg | IV | not captured | standing | page 187 |
| Other | adult | 2–4 mg | IV | not captured | standing | page 40 |
| Mild to moderate pain | adult | 2–10 mg | IV/IO | not captured | standing | page 118 |
| Mild to moderate pain | peds | 0.1–0.2 mg/kg | IV/IO | not captured | standing | page 118 |
Naloxone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Opioid overdose | adult | 0.4–2 mg | IN | not captured | standing | page 71 |
| Opioid overdose | adult | 0.4–2 mg | IV/IO/IM | not captured | standing | page 71 |
Nitroglycerin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| ACS / chest pain | adult | 0.4 mg | SL | not captured | standing | page 39 |
| CHF / pulmonary edema | adult | 0.4 mg | SL | not captured | standing | page 41 |
| Other | adult | 0.4 mg | SL | not captured | standing | page 41 |
Norepinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiogenic shock | adult | 2–4 mcg | IV/IO | not captured | standing | page 38 |
| Cardiogenic shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | page 38 |
| Hypotension / shock | adult | 2–4 mcg | IV/IO | not captured | standing | page 67 |
| Hypotension / shock | peds | 0.1–2 mcg/kg | IV/IO | not captured | standing | page 67 |
Ondansetron
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | page 52 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM | not captured | standing | page 53 |
| Nausea / vomiting | adult | 4–8 mg | PO | not captured | standing | page 52 |
| Nausea / vomiting | adult | 4–8 mg | IV/IO/IM | not captured | standing | page 53 |
Oral Glucose
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hypoglycemia | adult | 15 g | PO | not captured | standing | page 64 |
Pralidoxime
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Organophosphate poisoning | adult | 1–2 g | IV | not captured | standing | page 173 |
| Organophosphate poisoning | peds | 20–40 mg/kg | IV | not captured | standing | page 173 |
Procainamide
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Wide-complex tachycardia | adult | 20 mg | IV/IO | not captured | standing | page 190 |
| Wide-complex tachycardia | peds | 5 mg/kg | IV/IO | not captured | standing | page 190 |
Racemic Epinephrine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Asthma / bronchospasm | adult | 0.25–0.5 mL | NEB | not captured | standing | page 79 |
| Asthma / bronchospasm | adult | 0.25–0.5 mL | NEB | not captured | standing | page 190 |
| Asthma / bronchospasm | peds | 0.25–0.5 mL | NEB | not captured | standing | page 79 |
| Asthma / bronchospasm | peds | 0.25–0.5 mL | NEB | not captured | standing | page 190 |
| Croup | adult | 0.25–0.5 mL | NEB | not captured | standing | page 83 |
| Croup | peds | 0.25–0.5 mL | NEB | not captured | standing | page 83 |
| Other | adult | 0.25–0.5 mL | NEB | not captured | standing | page 190 |
| Other | peds | 0.25–0.5 mL | NEB | not captured | standing | page 190 |
Rocuronium
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–1.5 mg/kg | IV | not captured | standing | page 109 |
Sodium Bicarbonate
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Hyperkalemia | adult | 1 mEq/kg | IV | not captured | standing | page 191 |
| Hyperkalemia | peds | 1 mEq/kg | IV | not captured | standing | page 191 |
| Tricyclic overdose | adult | 1 mEq/kg | IV | not captured | standing | page 72 |
| Tricyclic overdose | peds | 1 mEq/kg | IV | not captured | standing | page 72 |
Succinylcholine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| RSI induction | adult | 1–2 mg/kg | IV | not captured | standing | page 108 |
| RSI induction | peds | 1–2 mg/kg | IV | not captured | standing | page 108 |
Thiamine
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Other | adult | 100 mg | IV/IM | not captured | standing | page 65 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 65 |
| Other | adult | 100 mg | IV/IM | not captured | standing | page 72 |
| Other | peds | 25 mg | IV/IM | not captured | standing | page 65 |
| Other | peds | 25 mg | IV/IM | not captured | standing | page 65 |
| Other | peds | 25 mg | IV/IM | not captured | standing | page 72 |
Tranexamic Acid
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Trauma / hemorrhage | adult | 1 g | IV | not captured | standing | page 67 |
Vasopressin
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Cardiac arrest | adult | 40 unit | IV | not captured | standing | page 193 |
Ziprasidone
| Indication | Population | Dose | Route | Repeat | Standing | Source |
|---|---|---|---|---|---|---|
| Agitation | adult | 10–20 mg | IM | not captured | standing | page 144 |